Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
CHADDS FORD, Pa., July 30 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) today reported financial results for the second quarter of 2009, including a full quarter of results of Indevus Pharmaceuticals, Inc., which Endo acquired during the first quarter.
STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained
ANTONY, France, July 15 /PRNewswire-FirstCall/ --
Million EUR 2008 08/07 2009 09/08
MEUR %Sales Var.% MEUR %Sales Var.%
Southern Europe (1) 26.7 71 15 28.5 68 7
Other EU countries (2) 9.3 24 20...
Web of Science(R) Renewals Remain Strong Despite Tough Economic Climate
PHILADELPHIA and LONDON, June 9 /PRNewswire/ -- The Healthcare and Science business of Thomson Reuters reported today that, despite difficult economic times, renewals of Web of Science (R) have remained strong, and many existing customers have even added new content to their portfolio of produc...
China Biologic Products Announces Strong First Quarter 2009 Results
TAI'AN, Shandong, May 18 /PRNewswire-Asia-FirstCall/ -- China Biologic
Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"),
one of the leading plasma-based pharmaceutical companies in the People's
Republic of China ("PRC"), reported strong
financial results for the f...
Healthy Advice Networks Achieves Strong Growth Despite Challenging Economy
Attributed to Delivering Business Results for Sponsoring Brands
CINCINNATI, May 12 /PRNewswire/ -- Healthy Advice Networks , the nation's leading provider of physician office-based patient-education programs, announces another record performance in 2008. In a challenging economic climate, t...
Shire begins the year with a strong performance
PHILADELPHIA and DUBLIN, April 30 /PRNewswire-FirstCall/ -- Shire plc
(LSE: SHP, NASDAQ: SHPGY ) the global specialty biopharmaceutical company,
announces results for the three months to March 31, 2009.
China Biologic Products Announces Strong 2008 Results
TAI'AN, China, April 1 /PRNewswire-Asia-FirstCall/ -- China Biologic
Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"),
one of the leading plasma-based pharmaceutical companies in the People's
Republic of China ("PRC"), reported financial results for the year ended
STALLERGENES: 2008: Strong Performance
ANTONY, France, March 24 /PRNewswire-FirstCall/ --
Growth in Results Sales up 16%, net Profit up 17%
- Sound Financial Position
- Proposed Increase in Dividend
The Board of Directors, meeting on 23 March 2009 under the chairmanship
of Albert SAPORTA, approved the 2...
Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008
New Molecular Tests and Increasing Case Volumes Drive 78 Percent Revenue Growth in the Fourth Quarter of 2008 as Compared to the Prior Year Period
ALISO VIEJO, Calif., March 11 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT ), a premier anatomic pathology and molecular testing ser...
Frost & Sullivan Forecasts Early Rebound: Strong Growth Ahead for Global Economy
MOUNTAIN VIEW, Calif., Feb. 17 /PRNewswire/ -- Frost & Sullivan, the
Growth Partnership Company, reaffirms its position that the economy is
regaining its strength, thanks in part to an unprecedented US $1 trillion
stimulus package from the US government and additional stimulus packages fro...
Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals
ORANGE COUNTY, Calif., Feb. 9 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today fourth quarter and year ended December 31, 2008 results. For ...
InformexUSA 2009 Opens to Strong Attendance
Most Comprehensive Program Offering In Show's History Draws Participants From A Broad Range of Industries Despite Uncertain Economic Climate
SAN FRANCISCO, Jan. 29 /PRNewswire/ -- The 2009 edition of InformexUSA officially opened its exhibition floors Wednesday with attendance expected to be ...
Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
Second quarter EPS of $0.44 -- increase of 110% from prior year
EXTON, Pa., Jan. 28 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY ), a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today repo...
Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
TARRYTOWN, N.Y., Jan. 23 /PRNewswire/ -- Aerolase Corporation, a leading manufacturer of next-generation portable lasers for aesthetic skin treatments, today announced that sales increased dramatically in 2008 over 2007. The company's unique product offerings in the aesthetic laser market helped t...
Novozymes Reports Strong 2008 Results
BAGSVAERD, Denmark, January 22 /PRNewswire/ -- Leading biotechnology
company Novozymes reports 13% sales growth in 2008. Earnings were also very
satisfactory. Growth outlook for 2009 of 8-13% in DKK in an uncertain market.
Strong long-term trends lead to new, increased targets and higher inves...
Sentrx Exits 2008 with Strong Growth
Sentrx, a New Jersey drug safety specialty firm, announced today that the company grew the number of pharmacovigilance outsourcing contracts by more than 50% in 2008. Revenues for the year increased 25% over 2007. The domestic service provider added long-term contracts in clinical trial and pos...
Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops
DuPont Leader says “Right Product, Right Acre” Key to Top Productivity.
Grand Forks, ND (Vocus) December 10, 2008 -– As seed technologies advance, matching specific genetic technologies to individual management practices and fields will become increasi...
China Biologic Products Reports Strong Third Quarter 2008 Results
TAI'AN, China, Nov. 12 /Xinhua-PRNewswire-FirstCall/ -- China Biologic
Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," the
"Company"), one of the leading plasma-based pharmaceutical companies in the
People's Republic of China ("PRC"), today reported financial results for
ACORN CRO Continues Growth in Strong Third Quarter
Oncology Focused Contract Research Organization Exceeds Expectations
MEMPHIS, Tenn., Nov. 10 /PRNewswire/ -- ACORN CRO, a Contract Research
Organization exclusively focused on oncology, announced today that its
third quarter had once again exceeded projections as the company continues
Varian, Inc. Reports Strong Fourth Quarter 2008 Results
- Sales Up 15% - Non-GAAP Operating Earnings Up 27%, GAAP Operating Earnings Up 32% - Non-GAAP Diluted EPS Up 29%, GAAP Diluted EPS Up 32%
PALO ALTO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Varian, Inc.
(NasdaqGS: VARI) today reported fourth fiscal quart...
OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services
Q3 2008 Contracts Total $3,970,647, up 137% Over Q3 2007
FT. LAUDERDALE, Fla., Oct. 29 /PRNewswire-FirstCall/ -- OmniComm
Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic
data capture solutions for clinical trials, today announced another
momentous quarter fo...
Shire's New Product Portfolio Delivers Strong Quarterly Performance
PHILADELPHIA and DUBLIN, Ireland, Oct. 29 /PRNewswire-FirstCall/ --
Shire plc (LSE: SHP, Nasdaq: SHPGY) the global specialty biopharmaceutical
company announces results for the three months to September 30, 2008.
Q3 2008 Financial Highlights
- Product sales up 31% to $713 million - Pro...
Cephalon Reports Another Strong Quarter
Record Sales of $490 Million, Up 14 Percent over Third Quarter 2007 Company Raises Full Year 2008 Sales and Earnings Guidance
Introduces 2009 Adjusted Net Income Guidance, Up 27 Percent over 2008
FRAZER, Pa., Oct. 28 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq:
CEPH) today repo...
Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan
Large-Scale Rapid Production, Increased Bioavailability
MOUNTAIN VIEW, Calif., Oct. 21 /PRNewswire/ -- An increased number of
diseases that are either incurable or difficult to treat allures clinicians
to the approach of stem cell therapy. Highly prized, due to their
Senetek Affirms Strong Financial Position
$16 Million Cash On Hand and No Debt
NAPA, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Senetek PLC (OTC
Bulletin Board: SNKTY), a life sciences company engaged in the development
of technologies that target the science of healthy aging, announced today
that the company continue...
Fufeng Announces 2008 Interim Results With Strong Sign of Recovery
Turnover Increased by 45.7%
Profit Attributable to Shareholders Increased Significantly by 161.7%
HONG KONG, Aug. 14 /Xinhua-PRNewswire/ -- Fufeng Group Limited
("Fufeng" or "the Group"; HKEx: 546), a leading vertically integrated
manufacturer of corn-based biochemical...
China Medicine Announces Strong Second Quarter 2008 Results
Revenues increased 40.8% to $11.6 million Net Income increased 118.8% to $2.5 million
GUANGZHOU, China, Aug. 13 /Xinhua-PRNewswire/ -- China Medicine
Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"),
a leading distributor and developer of p...
Atrium generates strong growth during the second quarter
Significant increase in revenues and net earnings from continued
operations of 165% and 157% respectively
All amounts are in US dollars.
QUEBEC CITY, Aug. 7 /PRNewswire-FirstCall/ - Atrium Innovations Inc.
(TSX: ATB), a recognized leading developer, manufacturer and marketer of
Confirmation of Strong Growth Over the First Half of 2008
Record Revenue of EUR1.55 Million (+45.5% at Constant Forex) Substantial Increase in Sales of the JAK2 Test: +169%
LUMINY, France, August 1 /PRNewswire-FirstCall/ -- IPSOGEN (Alternext -
FR0010626028 - ALIPS), a pioneer and key player in the development and
commercialization of m...
Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
BASINGSTOKE, England and PHILADELPHIA, July 31 /PRNewswire-FirstCall/
-- Shire Limited (LSE: SHP, NASDAQ: SHPGY) the global specialty
biopharmaceutical company announces results for the three months to June
Q2 2008 Financial Highlights
- Product sales up 40% to $706m - Produ...
Gentiva Reports Strong Second Quarter led by Home Health Segment
Raises Full Year Financial Outlook
MELVILLE, N.Y., July 31 /PRNewswire-FirstCall/ -- Gentiva Health
Services, Inc. (Nasdaq: GTIV ), the nation's leading provider of
comprehensive home health services, today reported strong
results, led by double-digit increas...
U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis
Survey shows hospital physicians, pulmonary and critical care clinicians, and researchers also concerned about overuse of antibiotics
DURHAM, N.C., July 24 /PRNewswire/ -- bioMerieux recently conducted two
surveys, fielded during conferences of the American Thoracic Society and
Society of ...
Genzyme Reports Strong Second-Quarter Growth
Delivers Solid Financial Performance While Building for the Future
CAMBRIDGE, Mass., July 23 /PRNewswire-FirstCall/ -- Genzyme Corporation
(Nasdaq: GENZ ) today reported strong
sales and profit growth in the second
quarter, along with significant progress in its commercial and clinical
Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
Company Posts Second Quarter EPS of $0.85 Per Diluted Share, An Increase of 31 Percent
DEERFIELD, Ill., July 17 /PRNewswire-FirstCall/ -- Baxter International
Inc. (NYSE: BAX ) today posted strong
financial results for the second
quarter of 2008 and raised its full...
Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter
Epilepsy Growth of 14% Fiscal 2009 Revenue Guidance
HOUSTON, June 11 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq:
CYBX) today announced results for the fourth quarter, and fiscal year,
ended April 25, 2008.
Key quarterly highlights
Atrium shows a strong financial performance for its first quarter
Increase of 98% in net earnings from continuing operations during the first quarter of 2008 to reach 10.5 million US dollars All amounts in US dollars
QUEBEC CITY, May 6 /PRNewswire-FirstCall/ - Atrium Innovations Inc.
(TSX: ATB), a recognized leading developer, ...
Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
- Company Posts Record Quarterly EPS of $0.58, 45% Above Prior Year, Based on Positive Operating Results and One-Time Legal Benefit -
- Total Revenues Increase 21% to Establish Quarterly Record of $122.6 Million, Product Sales Rise 16% to All-Time High of $101.5 Million -
- For 2008, ...
Genzyme Reports Strong First-Quarter Growth
Non-GAAP EPS Increased 22 Percent
CAMBRIDGE, Mass., April 23 /PRNewswire-FirstCall/ -- Genzyme
Corporation (Nasdaq: GENZ ) today reported results for the first quarter of
2008, which featured excellent revenue growth, continued operating
leverage, a significant increase in ...
Edwards Lifesciences Reports Strong First Quarter Results and Raises 2008 Guidance
Sales Growth Across All Product Lines - Transcatheter Valves Propel Heart Valve Sales Growth - Special Items Reduce Net Income by $15 Million
IRVINE, Calif., April 22 /PRNewswire-FirstCall/ -- Edwards Lifesciences
Corporation (NYSE: EW ), a world leade...
Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics
Pharsight Scientists Will Present at First Joint U.S. National Modeling and Simulation Meeting on March 11-12, 2008
MOUNTAIN VIEW, Calif., Mar. 4 /PRNewswire-FirstCall/ -- Pharsight
Corporation (Nasdaq: PHST ), a leading provider of software, strategic
consulting, and regulatory ...